192 related articles for article (PubMed ID: 33444798)
1. Model studies of advanced glycation end product modification of heterograft biomaterials: The effects of in vitro glucose, glyoxal, and serum albumin on collagen structure and mechanical properties.
Rock CA; Keeney S; Zakharchenko A; Takano H; Spiegel DA; Krieger AM; Ferrari G; Levy RJ
Acta Biomater; 2021 Mar; 123():275-285. PubMed ID: 33444798
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of advanced glycation end product formation and serum protein infiltration in bioprosthetic heart valve leaflets: Investigations of anti-glycation agents and anticalcification interactions with ethanol pretreatment.
Zakharchenko A; Rock CA; Thomas TE; Keeney S; Hall EJ; Takano H; Krieger AM; Ferrari G; Levy RJ
Biomaterials; 2022 Oct; 289():121782. PubMed ID: 36099713
[TBL] [Abstract][Full Text] [Related]
3. Poly-2-methyl-2-oxazoline-modified bioprosthetic heart valve leaflets have enhanced biocompatibility and resist structural degeneration.
Zakharchenko A; Xue Y; Keeney S; Rock CA; Alferiev IS; Stachelek SJ; Takano H; Thomas T; Nagaswami C; Krieger AM; Chorny M; Ferrari G; Levy RJ
Proc Natl Acad Sci U S A; 2022 Feb; 119(6):. PubMed ID: 35131859
[TBL] [Abstract][Full Text] [Related]
4. Age-related enhanced degeneration of bioprosthetic valves due to leaflet calcification, tissue crosslinking, and structural changes.
Xue Y; Kossar AP; Abramov A; Frasca A; Sun M; Zyablitskaya M; Paik D; Kalfa D; Della Barbera M; Thiene G; Kozaki S; Kawashima T; Gorman JH; Gorman RC; Gillespie MJ; Carreon CK; Sanders SP; Levy RJ; Ferrari G
Cardiovasc Res; 2023 Mar; 119(1):302-315. PubMed ID: 35020813
[TBL] [Abstract][Full Text] [Related]
5. Glycation and Serum Albumin Infiltration Contribute to the Structural Degeneration of Bioprosthetic Heart Valves.
Frasca A; Xue Y; Kossar AP; Keeney S; Rock C; Zakharchenko A; Streeter M; Gorman RC; Grau JB; George I; Bavaria JE; Krieger A; Spiegel DA; Levy RJ; Ferrari G
JACC Basic Transl Sci; 2020 Aug; 5(8):755-766. PubMed ID: 32875167
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of transcatheter heart valve biomaterials: Computational modeling using bovine and porcine pericardium.
Sulejmani F; Caballero A; Martin C; Pham T; Sun W
J Mech Behav Biomed Mater; 2019 Sep; 97():159-170. PubMed ID: 31125889
[TBL] [Abstract][Full Text] [Related]
7. The effects of the covalent attachment of 3-(4-hydroxy-3,5-di-tert-butylphenyl) propyl amine to glutaraldehyde pretreated bovine pericardium on structural degeneration, oxidative modification, and calcification of rat subdermal implants.
Christian AJ; Alferiev IS; Connolly JM; Ischiropoulos H; Levy RJ
J Biomed Mater Res A; 2015 Jul; 103(7):2441-8. PubMed ID: 25546235
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of transcatheter heart valve biomaterials: Biomechanical characterization of bovine and porcine pericardium.
Caballero A; Sulejmani F; Martin C; Pham T; Sun W
J Mech Behav Biomed Mater; 2017 Nov; 75():486-494. PubMed ID: 28826102
[TBL] [Abstract][Full Text] [Related]
9. Glycolaldehyde, a reactive intermediate for advanced glycation end products, plays an important role in the generation of an active ligand for the macrophage scavenger receptor.
Nagai R; Matsumoto K; Ling X; Suzuki H; Araki T; Horiuchi S
Diabetes; 2000 Oct; 49(10):1714-23. PubMed ID: 11016456
[TBL] [Abstract][Full Text] [Related]
10. In vivo biomechanical assessment of triglycidylamine crosslinked pericardium.
Sacks MS; Hamamoto H; Connolly JM; Gorman RC; Gorman JH; Levy RJ
Biomaterials; 2007 Dec; 28(35):5390-8. PubMed ID: 17822757
[TBL] [Abstract][Full Text] [Related]
11. Maillard reactions by alpha-oxoaldehydes: detection of glyoxal-modified proteins.
Sady C; Jiang CL; Chellan P; Madhun Z; Duve Y; Glomb MA; Nagaraj RH
Biochim Biophys Acta; 2000 Sep; 1481(2):255-64. PubMed ID: 11018716
[TBL] [Abstract][Full Text] [Related]
12. Reducing immunoreactivity of porcine bioprosthetic heart valves by genetically-deleting three major glycan antigens, GGTA1/β4GalNT2/CMAH.
Zhang R; Wang Y; Chen L; Wang R; Li C; Li X; Fang B; Ren X; Ruan M; Liu J; Xiong Q; Zhang L; Jin Y; Zhang M; Liu X; Li L; Chen Q; Pan D; Li R; Cooper DKC; Yang H; Dai Y
Acta Biomater; 2018 May; 72():196-205. PubMed ID: 29631050
[TBL] [Abstract][Full Text] [Related]
13. The susceptibility of bioprosthetic heart valve leaflets to oxidation.
Christian AJ; Lin H; Alferiev IS; Connolly JM; Ferrari G; Hazen SL; Ischiropoulos H; Levy RJ
Biomaterials; 2014 Feb; 35(7):2097-102. PubMed ID: 24360721
[TBL] [Abstract][Full Text] [Related]
14. N epsilon-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins.
Reddy S; Bichler J; Wells-Knecht KJ; Thorpe SR; Baynes JW
Biochemistry; 1995 Aug; 34(34):10872-8. PubMed ID: 7662668
[TBL] [Abstract][Full Text] [Related]
15. Effects of cyclic flexural fatigue on porcine bioprosthetic heart valve heterograft biomaterials.
Mirnajafi A; Zubiate B; Sacks MS
J Biomed Mater Res A; 2010 Jul; 94(1):205-13. PubMed ID: 20166221
[TBL] [Abstract][Full Text] [Related]
16. Studying Xenograft Rejection of Bioprosthetic Heart Valves.
Manji RA; Manji JS
Methods Mol Biol; 2020; 2110():227-243. PubMed ID: 32002912
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of mesangial growth factor and extracellular matrix synthesis by advanced glycation end products via a receptor-mediated mechanism.
Pugliese G; Pricci F; Romeo G; Pugliese F; Mené P; Giannini S; Cresci B; Galli G; Rotella CM; Vlassara H; Di Mario U
Diabetes; 1997 Nov; 46(11):1881-7. PubMed ID: 9356040
[TBL] [Abstract][Full Text] [Related]
18. Impact of free N
Holik AK; Stöger V; Hölz K; Somoza MM; Somoza V
Food Funct; 2018 Jul; 9(7):3906-3915. PubMed ID: 29972203
[TBL] [Abstract][Full Text] [Related]
19. Glyoxal-induced formation of advanced glycation end-products in type 1 collagen decreases both its strength and flexibility in vitro.
Kitamura KI; Hirayama J; Tabuchi Y; Minami T; Matsubara H; Hattori A; Suzuki N
J Diabetes Investig; 2021 Sep; 12(9):1555-1559. PubMed ID: 33605082
[TBL] [Abstract][Full Text] [Related]
20. The effects of collagen fiber orientation on the flexural properties of pericardial heterograft biomaterials.
Mirnajafi A; Raymer J; Scott MJ; Sacks MS
Biomaterials; 2005 Mar; 26(7):795-804. PubMed ID: 15350785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
